Business Daily Media

The Times

.

Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study

  • Written by ACN Newswire - Press Releases

Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study

SYDNEY, Apr 29, 2020 - (ACN Newswire) - The Asia-Pacific's largest specialist biotech CRO Novotech has been engaged for a Phase 2 COVID-19 study by biotech sponsor Karyopharm Therapeutics Inc.

Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study

The Phase 2 randomized, open-label, multicenter study will evaluate the activity and safety of two regimens of low dose oral selinexor in patients with...

The 95 Per Cent Failure Rate Is Not An AI Problem

Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...

New AR tech helping to solve field service skills crisis

AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...

For Midsize Companies, Global Payroll Systems Matter More to Business-Security Than You Think

When a midsize company expands across borders, its payroll operation becomes exponentially more complex. These organisations typically face a new ...

GEO and the AI search shift reshaping Australian and New Zealand business visibility

For years, one of the biggest digital marketing questions for businesses was ‘how do we get onto page one of Google?’ That question still matters, ...

Why self-service is reshaping fleet management for modern businesses

Fleet management today is constrained by fragmented systems and heavy administrative demands. A lot of the work still relies on booking vehicles and...

Fraud Prevention and security crucial as identity crime hits record highs in Australia

In a radically transformed risk landscape where the scale and speed of financial fraud have reached unprecedented levels, Australian businesses ar...